{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-278717","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2024-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.976751+00:00","generated_at":"2026-05-29T03:43:08.409558+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Candel prices $80M public offering of common stock and pre-funded warrants at $6.00/share","bullets":["Offering: 10,000,001 common shares at $6.00/share plus pre-funded warrants for 3,333,333 shares at $5.99/warrant.","Gross proceeds ~$80M; net proceeds ~$74.7M (or ~$86M if underwriters' 2M-share option is exercised).","Proceeds to fund development, including BLA submission for CAN-2409 in prostate cancer, and general corporate purposes.","Cash runway extended into Q1 2027; key data readouts expected in NSCLC/PDAC (Q1 2025) and recurrent glioblastoma (Q4 2025).","Offering expected to close Dec 16, 2024; joint bookrunners: Citigroup, BofA Securities, Canaccord Genuity."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-278717","json":"https://secwatch.observer/filing/0001193125-24-278717.json","markdown":"https://secwatch.observer/filing/0001193125-24-278717.md","text":"https://secwatch.observer/filing/0001193125-24-278717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000119312524278717/0001193125-24-278717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000119312524278717/d859956d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:43:08.409558+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}